US Biotech Leader Expands Global Operations Through Strategic Investment in Telangana

US-based biotechnology company Regeneron Pharmaceuticals has announced plans to establish a new Global Capability Centre (GCC) in Hyderabad, reinforcing India’s growing role in the global life sciences and healthcare innovation ecosystem. The upcoming centre is expected to become operational in the second half of 2026 and will support Regeneron’s worldwide business and research operations.

The Hyderabad GCC marks a significant milestone in Regeneron’s long-term growth strategy and reflects the company’s commitment to leveraging India’s deep talent pool in biotechnology, digital technologies, analytics, and artificial intelligence. The investment is expected to generate hundreds of high-skilled jobs over the coming years as the centre scales its operations.

Expanding Global Capabilities Across Critical Functions

The new facility will house teams supporting several strategic functions, including data management, statistical programming, clinical trial operations, artificial intelligence, digital technology, commercial operations, and advanced analytics. By establishing these capabilities in Hyderabad, Regeneron aims to enhance operational efficiency while accelerating innovation across its global pharmaceutical and biotechnology initiatives.

Founded and led by physician-scientists, Regeneron is recognized globally for its science-driven approach to developing innovative therapies. The company currently has multiple approved medicines and a robust development pipeline addressing a wide range of therapeutic areas.

Building on Existing India Operations

The Hyderabad GCC will complement Regeneron’s existing presence in India, following the establishment of its Bengaluru operations in 2022. The expansion highlights the increasing strategic importance of India in the company’s global operating model and reflects confidence in the country’s ability to support high-value scientific and technology functions.

Hyderabad Continues to Attract Global Life Sciences GCCs

Regeneron’s decision further strengthens Hyderabad’s reputation as one of India’s leading destinations for Global Capability Centres, particularly in the life sciences and healthcare sectors. The city has emerged as a preferred location for multinational organizations due to its strong research ecosystem, skilled workforce, advanced infrastructure, and growing expertise in biotechnology and digital innovation.

With more global healthcare and pharmaceutical companies establishing strategic operations in the region, Hyderabad continues to evolve into a key hub for innovation, research, and enterprise transformation.

Outlook

As global organizations increasingly seek specialized talent and innovation-driven capabilities, Regeneron’s Hyderabad GCC represents another important milestone in India’s GCC growth story. The centre is expected to play a crucial role in supporting the company’s future expansion while creating new opportunities for professionals in biotechnology, data science, AI, and clinical research.

Data Source : Link